2 Patents
- US125443792026Combination Therapy Using Ribociclib and Fulvestrant for the Treatment of HR+ Breast Cancer
Novartis AG
0 cites - US125443802026Combination Therapy Using Ribociclib and an Aromatase Inhibitor for the Treatment of HR+ Breast Cancer
Novartis AG
0 cites